Jun 19, 2020
Dupixent® (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Jun 18, 2020
Worldwide DNA Vaccine Market (2020 to 2022) - Increasing Focus on Genetic Vaccine Development
Jun 17, 2020
ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration With Regeneron
Jun 15, 2020
Sanofi's emerging oncology pipeline highlighted at the AACR Virtual Annual Meeting II
Jun 14, 2020
Sobi and Sanofi Donate up to 500 Million Additional IUs of Clotting Factor to WFH Humanitarian Aid Program
Jun 14, 2020
Sanofi and Sobi donate up to 500 million additional IUs of clotting factor to WFH Humanitarian Aid Program
Jun 11, 2020
Two Science Publications Highlight Potential of REGN-COV2 Anti-Viral Antibody Cocktail to Protect Against SARS-CoV-2 Escape Mutants
Jun 11, 2020
Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19
Jun 11, 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Jun 08, 2020
Previously Vilified, Big Pharma Steps Up in COVID-19 Fight
Jun 01, 2020
Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
May 29, 2020
Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents in IPR Proceedings
May 29, 2020
Libtayo® (cemiplimab-rwlc) Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO 2020 Show Durable Responses that Deepen Over Time
May 27, 2020
iOnctura Appoints Industry Veteran Dr. Joanna Horobin as Chair
May 27, 2020
Insulin Market Report 2020: Includes Revenue Data (2013-2022) for Novo Nordisk, Sanofi Aventis, Eli Lilly, Merck & Co, and Beckton Dickinson
May 27, 2020
Vaccines & Drugs - Revised Market Projections to 2025 due to COVID-19
May 26, 2020
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
May 25, 2020
Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock Repurchase
May 22, 2020
Dupixent® (dupilumab) Eosinophilic Esophagitis Trial Meets Both Co-Primary Endpoints
May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team